Showing results (21-30 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|June 1, 1990
A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced choreaA S Walters, D McHale, J I Sage, et al.Clinical Neuropharmacology|March 17, 2011
Citalopram-induced parkinsonian syndrome: case reportVladimir Miletić, Maja ReljaClinical Neuropharmacology|October 23, 1997
Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact miceS I Deutsch, R B Rosse, J MastropaoloClinical Neuropharmacology|October 23, 1997
Relationship between levodopa concentration, dyskinesias, and motor effect in parkinsonian patients: a 3-year follow-up studyM Contin, R Riva, P Martinelli, et al.Clinical Neuropharmacology|October 23, 1997
Lack of adverse interactions between concomitantly administered selegiline and citalopramK Laine, M Anttila, E Heinonen, et al.Clinical Neuropharmacology|June 1, 1994
Side effects of the catechol-O-methyl-transferase inhibitor Ro 40-7592 in rabbitsJ M Garrido, M A Mena, C Correa, et al.Clinical Neuropharmacology|August 1, 1994
Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective studyR B Rosse, J P Collins, M Fay-McCarthy, et al.Clinical Neuropharmacology|August 1, 1994
Effects of enhanced striatal dopamine turnover in vivo on glutathione oxidationD A Loeffler, A J DeMaggio, P L Juneau, et al.Clinical Neuropharmacology|August 1, 1994
Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administrationR Bordet, J Benhadjali, C Libersa, et al.Clinical Neuropharmacology|October 1, 1994
Discontinuation of prolonged bromocriptine therapy in Parkinson's disease patients with uncontrolled motor oscillationsS Giménez-Roldán, D MateoPageof 236